Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet is an allopathic medicine The correct dosage of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet is used -
Severe
Moderate
Mild
Common
Is the use of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet safe for pregnant women?
It is not known what effect StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet will have on pregnant women, because no research work has been carried out on this till date.
Is the use of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet safe during breastfeeding?
There is no research available on the side effects of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet in breastfeeding women. Therefore, its impact is unknown.
What is the effect of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet on the Kidneys?
StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet is completely safe for kidneys.
What is the effect of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet on the Liver?
Using StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet does not have any harmful effects on the liver.
What is the effect of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet on the Heart?
There are no any side effects of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet for the heart.
StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet unless your doctor advises you to do so -
Is this StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet habit forming or addictive?
Forming a habit of StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet has not been reported.
Interaction between Food and StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet
Taking StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet with food does not cause any problems.
Interaction between Alcohol and StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet with alcohol will be.
No, StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet can't be taken at the same time until unless prescribed by your doctor because it can significantly reduce the bioavailability of amoxicillin due to which the effectiveness of amoxicillin will decrease.
No, StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet does not cause weight gain. Please consult your doctor if you are experiencing weight gain after consuming this drug.
No, StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet is not banned in India. It has been approved by CDSCO.
StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet is a brand name of diclofenac. It is a prescription drug that belongs to the class of medication called NSAIDs (Nonsteroidal Antiinflammatory Drugs). It is used in the treatment of rheumatoid arthritis, osteoarthritis, bursitis, ankylosing spondylitis, toothache, dysmenorrhoea, renal colic, post-traumatic disorder and post-operative inflammatory conditions which affords quick relief from pain and wounds and edema (swelling).
Yes, StayHappi Paracetamol + Diclofenac Potassium + Trypsin & Chymotrypsin Tablet can cause the blood to become less viscous (thin).
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)